Skip to main content
Top
Published in: Current Treatment Options in Neurology 3/2011

01-06-2011 | Neuroimmunology

Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders

Authors: Myrna R. Rosenfeld, MD, PhD, Josep Dalmau, MD, PhD

Published in: Current Treatment Options in Neurology | Issue 3/2011

Login to get access

Opinion statement

Synaptic autoimmunity may result in a wide variety of symptoms, including catatonia, psychosis, movement disorders, short-term memory deficits, and refractory seizures, so these patients are seen by a wide spectrum of practitioners, who need to be aware of these disorders. In some cases, these disorders occur as a paraneoplastic manifestation of an associated cancer. However, in contrast to the well-known paraneoplastic neurologic disorders of the central nervous system that predominate in older individuals, these novel disorders often affect children and young adults. Additionally, for some syndromes, the presence of a tumor does not necessarily indicate a poor prognosis. Successful treatment of the tumor and immunotherapy often result in recovery, supporting the use of surgery for severely ill patients. In all syndromes, deficits may be reversible despite the duration or severity of symptoms. For example, patients with anti–NMDA-receptor encephalitis who had been in a coma or ventilated for 6–10 months have had full recovery after appropriate treatment.
Literature
1.
go back to reference Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.PubMedCrossRef Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.PubMedCrossRef
2.•
go back to reference Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34.PubMedCrossRef Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34.PubMedCrossRef
3.••
go back to reference Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85.PubMedCrossRef Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85.PubMedCrossRef
4.
go back to reference Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9.PubMedCrossRef Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9.PubMedCrossRef
5.
go back to reference Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66:704–9.PubMedCrossRef Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66:704–9.PubMedCrossRef
6.
go back to reference Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58:594–604.PubMedCrossRef Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58:594–604.PubMedCrossRef
7.••
go back to reference Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.PubMedCrossRef Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.PubMedCrossRef
8.••
go back to reference Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–8.PubMedCrossRef Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11–8.PubMedCrossRef
9.•
go back to reference Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504–11.PubMedCrossRef Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504–11.PubMedCrossRef
10.
go back to reference Wandinger K-P, Saschenbrecker S, Stoecker W, Dalmau J Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2010 Oct 14 (Epub ahead of print). Wandinger K-P, Saschenbrecker S, Stoecker W, Dalmau J Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2010 Oct 14 (Epub ahead of print).
11.
go back to reference Ferioli S, Dalmau J, Kobet CA, et al. Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol. 2010;67:250–1.PubMedCrossRef Ferioli S, Dalmau J, Kobet CA, et al. Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol. 2010;67:250–1.PubMedCrossRef
12.
go back to reference Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74:265–7.PubMedCrossRef Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74:265–7.PubMedCrossRef
13.••
go back to reference Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–76.PubMedCrossRef Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–76.PubMedCrossRef
14.
go back to reference Boronat A, Sabater L, Saiz A, Dalmau J, Graus F GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology. 2010;(in press). Boronat A, Sabater L, Saiz A, Dalmau J, Graus F GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurological disorders. Neurology. 2010;(in press).
15.
go back to reference Andrade DM, Tai P, Dalmau J, Wennberg R Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology. 2010;(in press). Andrade DM, Tai P, Dalmau J, Wennberg R Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis. Neurology. 2010;(in press).
16.
go back to reference Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–48.PubMedCrossRef Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–48.PubMedCrossRef
17.
go back to reference Gu W, Brodtkorb E, Steinlein OK LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol. 2002;52:364–7.PubMedCrossRef Gu W, Brodtkorb E, Steinlein OK LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol. 2002;52:364–7.PubMedCrossRef
18.
go back to reference Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335–41.PubMedCrossRef Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet. 2002;30:335–41.PubMedCrossRef
19.
go back to reference Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK: Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol. 2010;42:213–4.PubMedCrossRef Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK: Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol. 2010;42:213–4.PubMedCrossRef
20.
go back to reference Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324–6.PubMedCrossRef Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324–6.PubMedCrossRef
21.
go back to reference Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology. 2008;71:1921–3.PubMedCrossRef Ishiura H, Matsuda S, Higashihara M, et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology. 2008;71:1921–3.PubMedCrossRef
22.
go back to reference Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.Neurology. 2010;74:1550–1.PubMedCrossRef Wong-Kisiel LC, Ji T, Renaud DL, et al. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.Neurology. 2010;74:1550–1.PubMedCrossRef
23.
go back to reference Prüss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735–9.PubMedCrossRef Prüss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75:1735–9.PubMedCrossRef
Metadata
Title
Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders
Authors
Myrna R. Rosenfeld, MD, PhD
Josep Dalmau, MD, PhD
Publication date
01-06-2011
Publisher
Current Science Inc.
Published in
Current Treatment Options in Neurology / Issue 3/2011
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-011-0116-y

Other articles of this Issue 3/2011

Current Treatment Options in Neurology 3/2011 Go to the issue

Movement Disorders

Tardive Dyskinesia

Neuroimmunology

Behçet’s Disease